Dopo la trasmissione Report (RAI3) del 29 Dicembre 2024 sull'impianto percutaneo della valvola aortica cardiaca (TAVI) sono necessarie importanti precisazioni per i pazienti e i loro familiari. Leggi la notizia completa https://t.co/bUsiKlBW28
New evidence on coronary revascularization in TAVI setting from the REVASC-TAVI Registry: should we pospone PCI after TAVI? @EuroInterventio https://t.co/TksgwJEvDT
#TCT2033#OPERA_TAVI
PS #SEV v #BEV
🔩1° safety EP: SEV 69.1% v BEV 82.6% P<0.01) driven by ⬆️
-pacer SEV 17.9% v BEV 10.1% P<0.01)
-Stroke SEV 2.3% v BEV 0.7% P=0.03)
🔩 PVL similar SEV 3.2% v BEV 2.3% P=0.41)
🔩 ⬇️ MG median SEV 7 v BEV 12 mmHg P<0.01)
https://t.co/gsBJ7KyY39
Use of an optimized logistics for TAVI workup and procedure developed during the COVID-19 pandemic is safe and effective, allowing the minimization of hospital resources.
https://t.co/N90SSBvDuX
My Toolkit 🧰⚙️🔧: how to improve the effectiveness of hemostasis of large bore arteriotomy using a combined approach of suture- and plug-based closure devices.
@barbanti_marco & @costagiuliano90 share a step by step method reviewed by @AlexWol76944346
https://t.co/eP4aMpMR2y